AUGX AUGMEDIX INC

Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2024

Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2024

SAN FRANCISCO, April 30, 2024 (GLOBE NEWSWIRE) --  (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, announced today it will release first quarter 2024 results after the market closes on Monday, May 13, 2024. Following the release, management will host a conference call that same day at 1:30 p.m. PT / 4:30 p.m. ET.

  • Live conference call: 877-407-3982 (Toll-Free) and 201-493-6780 (International)
  • Live webcast:

An archived replay will be available following the call on Augmedix’s IR website at .

About Augmedix

Augmedix (Nasdaq: AUGX) empowers clinicians to connect with patients by liberating them from administrative burden through the power of ambient AI, data, and trust.

The platform transforms natural conversations into organized medical notes, structured data, and point-of-care notifications that enhance efficiency and clinical decision support.

Incorporating data from millions of interactions across all care settings, Augmedix collaborates with hospitals and health systems to improve clinical, operational, and financial outcomes.

Augmedix is headquartered in San Francisco, CA, with offices around the world. To learn more, visit .

Contact Information

Investors:

Matt Chesler, CFA

FNK IR

(646) 809-2183



Media:

Kaila Grafeman

Augmedix

 



EN
30/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AUGMEDIX INC

 PRESS RELEASE

Augmedix Delivers 40% Revenue Growth for First Quarter of 2024

Augmedix Delivers 40% Revenue Growth for First Quarter of 2024 SAN FRANCISCO, May 13, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three months ended March 31, 2024. “Augmedix delivered in-line first quarter performance, with 40% revenue growth, 143% net revenue retention and 47.1% gross margins,” commented Manny Krakaris, Augmedix CEO. “We are confident about our positioning within the medical documentation market, and expect to report continued growth throughout the rest of th...

 PRESS RELEASE

Augmedix to Participate in Upcoming Investor Conferences in May and Ju...

Augmedix to Participate in Upcoming Investor Conferences in May and June 2024 SAN FRANCISCO, May 03, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced that its management team will participate in the following four investor conferences in May and June 2024. RBC Capital Markets Global Healthcare Conference (New York): Management will participate in a fireside chat on May 15 at 10:30 a.m. ET, and be available for 1x1 investor meetings. The webcast link for the fireside chat can be found at .Benchmark Hea...

 PRESS RELEASE

Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2...

Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2024 SAN FRANCISCO, April 30, 2024 (GLOBE NEWSWIRE) --  (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, announced today it will release first quarter 2024 results after the market closes on Monday, May 13, 2024. Following the release, management will host a conference call that same day at 1:30 p.m. PT / 4:30 p.m. ET. Live conference call: 877-407-3982 (Toll-Free) and 201-493-6780 (International)Live webcast: An archived replay will be available following the call on Augmedix’s IR webs...

 PRESS RELEASE

Augmedix Awarded on Newsweek’s World’s Best Digital Health Companies 2...

Augmedix Awarded on Newsweek’s World’s Best Digital Health Companies 2024 List SAN FRANCISCO, April 25, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, has been named on Newsweek’s list of The World’s Best Digital Health Companies 2024. This prestigious award was presented by Newsweek and Statista Inc., the world-leading statistics portal and industry ranking provider. The list of awardees was unveiled on April 24th, 2024, and is available on the . Augmedix's inclusion highlights its commitment to empowering clinicians by relievi...

 PRESS RELEASE

Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Med...

Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments Following incubation with HCA Healthcare EDs, Augmedix announces the general availability of Augmedix Go in emergency departments SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced the general availability of for emergency departments (EDs), marking the launch of the industry’s first fully-automated, generative AI (GenAI) powered medical documentation product for EDs ac...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch